Document is current
Any future updates will be listed below
-
Authors
Földi, Tamás https://orcid.org/0000-0001-8364-508X
Szoboszlay, Miklos https://orcid.org/0000-0001-5736-2967
Chadaide, Zoltán
Radics, Bence
Horváth, Bálint https://orcid.org/0009-0004-6913-6667
Vecsernyés, Endre
Langó, István
Ráfi, Péter
Pejin, Andrea
Barcsai, Lívia https://orcid.org/0000-0002-5646-8265
Kozák, Gábor https://orcid.org/0000-0002-3473-9351
Forgó, Nóra
Furuglyás, Kristóf
Nagy, Olivér https://orcid.org/0000-0002-6599-6799
Nagy, Anett J.
Laszlovszky, Tamás
Somogyvári, Zoltán
Lőrincz, Magor L. https://orcid.org/0000-0001-5240-1904
Devinsky, Orrin https://orcid.org/0000-0003-0044-4632
Berényi, Antal https://orcid.org/0000-0003-0084-8530
- License Information
-
More Information
Article History
Received: 6 February 2025
Accepted: 7 April 2026
First Online: 21 April 2026
Competing interests
: A.B. is the owner of Amplipex LLC. Szeged, Hungary a manufacturer of signal-multiplexed neuronal amplifiers. A.B. is the CEO of Neunos ZRt, Szeged, Hungary, a company developing neurostimulator devices, and has equity in Blackrock Neurotech. He is listed as an inventor on patents and patent applications related to ISP stimulation and various aspects of closed-loop neurostimulation. O.D. receives grant support from NINDS, NIMH, MURI, CDC, and NSF. He has equity and/or compensation from the following companies: Blackrock Neurotech, Tilray, Tevard Biosciences, Regel Biosciences, Script Biosciences, Actio Biosciences, Empatica, Ajna Biosciences, and California Cannabis Enterprises (CCE). He has received consulting fees or equity options from Emotiv, Ultragenyx, and Praxis Precision Therapeutics. He holds patents for the use of cannabidiol in treating neurological disorders, but these are owned by GW Pharmaceutical,s and he has waived any financial interests. He holds other patents in molecular biology. He is the managing partner of PhiFund Ventures. All other authors declare no competing interests.
